Vanda Pharmaceuticals | VNDA - Ebitda





Ebitda Değişiklik Tarih
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
J&J USD 8.27B 1.08B 2026-03
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -1.26B 468M 2026-03
Novartis USD 5.41B 431M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 3.69B 375M 2026-06
Takeda JPY 364.46B 214.21B 2026-06
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Veracyte USD 43.96M 1.16M 2026-06